Article
Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.
PloS one - 1 Jan 2016
West James D, Carrier Erica J, Bloodworth Nathaniel C, Schroer Alison K, Chen Peter, Ryzhova Larisa M, Gladson Santhi, Shay Sheila, Hutcheson Joshua D, Merryman W David
Abstract excerpt
Serotonergic anorexigens are the primary pharmacologic risk factor associated with pulmonary arterial hypertension (PAH), and the resulting PAH is clinically indistinguishable from the heritable form of disease, associated with BMPR2 mutations. Both BMPR2 mutation and agonists to the serotonin receptor HTR2B have been shown to cause activation of SRC tyrosine kinase; conversely, antagonists to HTR2B inhibit SRC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
